Edaravone

SKU: orb1310644

Description

Edaravone (MCI-186) is a potent free radical scavenger clinically used for acute ischemic stroke. It is widely applied in neuroscience research to study oxidative stress mechanisms in models of cerebral infarction, both in vitro and in vivo.

Research Area

Cell Biology, Metabolism Research, Protein Biochemistry

Images & Validation

−

Key Properties

−

CAS Number	89-25-8
MW	174.20
Purity	>99.99% (May vary between batches)
Formula	C₁₀H₁₀N₂O
SMILES	CC1=NN(C(=O)C1)C1=CC=CC=C1
Target	MMP,Free radical scavengers,Apoptosis
Solubility	5% DMSO+40% PEG300+5% Tween80+50% Saline:4 mg/mL (22.96 mM);DMSO:247 mg/mL (1417.91 mM)

Bioactivity

−

In Vivo	Edaravone optimizes the state of NOS by reducing the detrimental isoforms iNOS and nNOS, while increasing the beneficial eNOS, thus favoring neuroprotection in ischemic stroke. It inhibits oxidation and enhances eNOS expression without boosting production, improving and preserving cerebral blood flow during reperfusion without necessitating peroxynitrite formation. Edaravone exerts its neuroprotective effect by mitigating neuronal damage from cerebral ischemia and inhibiting endothelial injury. Read more...
In Vitro	Edaravone significantly improves neurological function in animals. Treatment with edaravone substantially reduces TUNEL-positive apoptotic cells and increases the expression of Bcl-2, while decreasing the immunoreactivity of Bax protein in the peri-infarct area. The research demonstrates that edaravone provides excellent protection against ischemic/reperfusion-induced brain injury through a Bcl-2/Bax protein-dependent anti-apoptotic mechanism. Following a 24-hour infusion of edaravone into murine brain tissue, there is a notable reduction in infarct volume and amelioration of neurological deficits. In the early stages post-reperfusion, edaravone significantly inhibits the accumulation of HNE-modified proteins and 8-OHdG in the penumbral region, reduces the expression of iNOS, diminishes microglial activation, and lowers the formation of nitrotyrosine. Edaravone also markedly attenuates renal function and pathological outcomes in rat kidneys, significantly reducing free radical production in renal tubular epithelial cells as indicated by fluorescence. Read more...
Cell Research	Cell viability is quantified by MTT assay and trypan blue staining. MTT (5 mg/mL, 20 μL) is added to each well and incubated for 4 h at 37°C after the drug treatments. The medium is removed and the cell pellet is dissolved in DMSO. Then, the optical density (OD) values are measured at 570 nm using an ELISA reader. Read more...

Storage & Handling

−

Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

Edaravone, Freeradicalscavengers, Free radical scavengers, Matrix metalloproteinases, MCI 186, MCI186, MCI-186, inhibit, Inhibitor, MMP, Apoptosis

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Compound Identifiers

PubChem CID

4021 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols

Edaravone (orb1310644)

Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

No reviews yet

CAS Number:	1228765-67-0
MW:	179.23
Formula:	C₁₀H₁₀N₂O

CAS Number:	177415-76-8
MW:	346.38
Formula:	C₂₀H₁₈N₄O₂

Purity:	>98%(HPLC)
CAS Number:	89-25-8
MW:	174.2
Formula:	C₁₀H₁₀N₂O

Edaravone

Description

Research Area

Images & Validation

Key Properties

Bioactivity

Storage & Handling

Alternative Names

Similar Products

Edaravone-d5 [orb1992870]

Edaravone (Standard) [orb3139607]

Edaravone dimer impurity [orb3136871]

Edaravone [orb1223731]

Quality Guarantee

Compound Identifiers

Key Properties

Documents Download

Request a Document

Protocol Information

Edaravone (orb1310644)

Step 1: Enter information below

Step 2: Enter the in vivo formulation

Available Sizes

Email

UK Office

US Office

CN Office

Distributors